BB

Beenaben Bipinchandra Patel

Active Director Director DIN 02828980
DIN 02828980 First appointment Jul 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Jul 2019
Shareholding value •••• Premium profile

About Beenaben Bipinchandra Patel

Data last updated:

Beenaben Bipinchandra Patel is a Director at Elixir Pharma Chem Private Limited (since 2023), Director at Elixir Remedies Private Limited (since 2019) and Director at Pranav Chemicals (India) Private Limited (since 2024). The companies operate in Pharma, Wood and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹42.89 Cr; the largest is Elixir Pharma Chem Private Limited at ₹41.04 Cr (FY 2025). Earlier, Beenaben Bipinchandra Patel was a Director at Chimerical Lifesciences Private Limited (2020–2021).

DIN 02828980
Primary Designation Director
Industry Pharma
First Appointment 22 Jul 2019
Oldest Company Age 11 yrs
Largest company Elixir Pharma Chem Private Limited · ₹41.04 Cr (FY 2025)
Combined revenue ₹42.89 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Elixir Pharma Chem Private Limited U46497GJ2023PTC143193
Director24 Jul 20232023₹41.04 Cr (FY 2025)Active
Elixir Remedies Private Limited U24230GJ2015PTC084299
Director22 Jul 20192015₹1.85 Cr (FY 2024)Active
Director30 Oct 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Jan 20202018₹3.4 Lakh (FY 2020)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Elixir Remedies Private Limited
Pranav Chemicals (India) Private Limited
Elixir Pharma Chem Private Limited
Chimerical Lifesciences Private Limited
Premium access

Shareholding and investment profile for Beenaben Bipinchandra Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Beenaben Bipinchandra Patel

Beenaben Bipinchandra Patel currently holds 3 directorships: Elixir Pharma Chem Private Limited (Director, since 24 Jul 2023, revenue ₹41.04 Cr (FY 2025)); Elixir Remedies Private Limited (Director, since 22 Jul 2019, revenue ₹1.85 Cr (FY 2024)); Pranav Chemicals (India) Private Limited (Director, since 30 Oct 2024).

Beenaben Bipinchandra Patel was first appointed on 22 Jul 2019 as Director at Elixir Remedies Private Limited. The most recent appointment on record is 30 Oct 2024 at Pranav Chemicals (India) Private Limited.

The 2 current companies of Beenaben Bipinchandra Patel that report revenue have a combined latest revenue of ₹42.89 Cr: Elixir Pharma Chem Private Limited ₹41.04 Cr (FY 2025); Elixir Remedies Private Limited ₹1.85 Cr (FY 2024).

Beenaben Bipinchandra Patel held 1 earlier board appointment: Chimerical Lifesciences Private Limited (Director, 03 Jan 2020 to 06 Jan 2021).

The current boards of Beenaben Bipinchandra Patel's companies include Bipinchandra Kacharabhai Patel (Elixir Pharma Chem Private Limited), Daleep Kumar Malhotra (Elixir Pharma Chem Private Limited), Preet Bipinchandra Patel (Elixir Pharma Chem Private Limited), Darshan Arvindbhai Andani (Elixir Remedies Private Limited), Jatinkumar Gunvantbhai Andani (Elixir Remedies Private Limited), Jigneshkumar Chimanlal Patel (Elixir Remedies Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available